Abera Bioscience (ABERA.SL) Osake Kurssi

Abera Bioscience AB engages in the research and development of pharmaceutical products. The company is headquartered in Uppsala, Uppsala and currently employs 5 full-time employees. The company went IPO on 2021-02-24. Abera Bioscience is platform and vaccine development company active in the medical, molecular and microbiological field. The Company’s purpose is to develop vaccine candidates based on its vaccine delivery platform to late pre-clinical or early clinical phase and to find licensing partners for further development of the vaccines. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and immunooncology. The business is located around the Nordic market.